ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,025Medicare Part D Prescriptions Filled, Including Refills

Rank: 223 out of 944

$380K Total Retail Price of All Prescriptions

Rank: 371 out of 944

351 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
44% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Wisconsin
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 351 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

5% of this provider’s 351 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 8,124 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$42 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Wisconsin
LISINOPRIL 482 452 1 3
WARFARIN SODIUM 451 404 2 7
POTASSIUM CHLORIDE 344 327 3 15
SIMVASTATIN 323 317 4 1
FUROSEMIDE 273 257 5 6
LEVOTHYROXINE SODIUM 268 250 6 2
AMLODIPINE BESYLATE 262 238 7 5
OMEPRAZOLE 260 218 8 4
HYDROCHLOROTHIAZIDE 239 210 9 9
ATENOLOL 224 203 10 11
METOPROLOL SUCCINATE 194 175 11 14
METOPROLOL TARTRATE 156 140 12 8
METFORMIN HCL 153 115 13 12
ATORVASTATIN CALCIUM 137 130 14 13
LOSARTAN POTASSIUM 129 118 15 16
FENOFIBRATE 127 108 16 58
GABAPENTIN 116 84 17 18
SERTRALINE HCL 110 70 18 23
LANTUS 106 98 19 46
CITALOPRAM HBR 101 92 20 19
ALENDRONATE SODIUM 91 78 21 20
PRAVASTATIN SODIUM 86 75 22 17
SPIRONOLACTONE 83 83 23 44
MIRTAZAPINE 82 80 24 35
DIGOXIN 82 75 24 39
DILT-XR 81 81 26 310
PREDNISONE 80 77 27 32
DONEPEZIL HCL 80 80 27 24
CARVEDILOL 80 68 27 30
DIOVAN 78 78 30 38
CLOPIDOGREL 78 71 30 36
TAMSULOSIN HCL 77 71 32 27
FENTANYL 77 68 S2 32 57
GLIPIZIDE XL 76 76 34 136
ZOLPIDEM TARTRATE 72 66 35 25
ROPINIROLE HCL 68 68 36 96
HYDROCODONE-ACETAMINOPHEN 66 59 S3 37 10
FINASTERIDE 66 60 37 83
ESCITALOPRAM OXALATE 66 52 37 98
ALLOPURINOL 63 56 40 22
PLAVIX 62 57 41 55
ISOSORBIDE MONONITRATE ER 60 60 42 52
INSULIN SYRINGE 58 51 43 121
LEVOFLOXACIN 58 52 43 117
TRAMADOL HCL 56 40 45 21
OXYCODONE HCL 56 54 S2 45 50
NOVOLOG 55 50 47 93
ZETIA 53 53 48 59
FLUTICASONE PROPIONATE 53 38 48 40
GEMFIBROZIL 50 49 50 72
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 13, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.